T Stanes and Company Limited
₹ 824▲0.00%(0.00)
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 0.87
- Debt to equity
- 0
- ROE (%)
- 11.33%
- Book value
- ₹952.42
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE420F01011
Figures in cr ·
Financials
| P&L Statement | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 496 | 440 | 527 |
| EBITDA | 26 | 26 | 36 |
| OPM | 5.24 | 5.91 | 6.83 |
| PBT | 24 | 25 | 32.7 |
| PAT | 17 | 19 | 24.4 |
| EPS | 72.03 | 80.51 | 103.39 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| A. Krishnamoorthy | Chairman | 30+ yrs experience | — |
| Lakshmi Narayanan | Director | 25+ yrs experience | — |
Frequently asked questions
Common questions on T Stanes and Company Limited—tap a row to read the answer.
Q.1What does T Stanes and Company Limited do?
T Stanes and Company Limited is one of India's oldest business groups with a legacy spanning more than 150 years. The company operates across multiple sectors, including agriculture, tea and coffee plantations, fertilizers, retail, engineering products, and industrial solutions. Its diversified business model helps serve customers across various industries while maintaining a strong presence in South India.
Q.2Can I invest in T Stanes and Company Limited shares before a public listing?
Yes. If the company's shares are available in the unlisted market, eligible investors can purchase them through authorized intermediaries. Since these shares are not traded on stock exchanges, transactions are completed through private transfers and settled in a Demat account after all required documentation is completed.
Q.3How can I sell T Stanes and Company Limited unlisted shares?
You can sell your T Stanes and Company Limited shares through a buyer in the unlisted market. Once the sale price is agreed upon, the shares are transferred from your Demat account to the buyer's account, and payment is completed according to the agreed settlement process.
Q.4Is it legal to buy and sell T Stanes and Company Limited unlisted shares in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction follows applicable regulations. Investors should ensure that shares are transferred through a valid Demat account and that all documentation complies with regulatory requirements.
Q.5What factors should investors evaluate before buying T Stanes and Company Limited shares?
Before investing, consider the company's financial performance, business diversification, revenue growth, profitability, management quality, industry outlook, corporate governance, valuation, and future expansion plans. Since unlisted shares have limited liquidity, investors should also assess their investment horizon and risk tolerance.
Q.6Does T Stanes and Company Limited have any IPO plans?
As of now, there is no officially announced timeline for an Initial Public Offering (IPO). Investors interested in potential listing opportunities should monitor company announcements and regulatory filings for any future developments.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
